The loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity

The Peroxisome Proliferator-Activated Receptor α is dispensable for cold-induced adipose tissue browning in mice

(2018) Merel Defour et al.   Molecular Metabolism

Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice

(2018) Chad N. Brocker et al.   JOURNAL OF LIPID RESEARCH

Physiological Mechanisms of Weight Gain−Induced Steatosis in People With Obesity

(2016) Elisa Fabbrini et al.   GASTROENTEROLOGY

Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity

(2016) Sadeesh K. Ramakrishnan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Bilirubin Binding to PPARα Inhibits Lipid Accumulation

(2016) David E. Stec et al.   PLoS One

PPAR-α agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice

(2015) Tamiris Lima Rachid et al.   CELL BIOCHEMISTRY AND FUNCTION

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease

(2015) Alper Sonmez et al.   Journal of Clinical Lipidology

Biliverdin reductase isozymes in metabolism

(2015) Luke O’Brien et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

PPAR  and Sirt1 Mediate Erythropoietin Action in Increasing Metabolic Activity and Browning of White Adipocytes to Protect Against Obesity and Metabolic Disorders

(2013) L. Wang et al.   DIABETES

Protein Phosphatase 5 Mediates Lipid Metabolism through Reciprocal Control of Glucocorticoid Receptor and Peroxisome Proliferator-activated Receptor-γ (PPARγ)

(2011) Terry D. Hinds et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

(2010) Jody Dushay et al.   GASTROENTEROLOGY

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects

(2009) Jing Xu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

The effect of PPAR-α agonism on apolipoprotein metabolism in humans

(2009) Ashish Shah et al.   ATHEROSCLEROSIS

Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats

(2009) Ahmed A. Elmarakby et al.   CLINICAL SCIENCE

Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity

(2009) Eric D. Berglund et al.   ENDOCRINOLOGY

Regulation of Sterol Transport between Membranes and NPC2†

(2008) Zhi Xu et al.   BIOCHEMISTRY

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1: A Link Between Insulin and Lipid Metabolism

(2008) A. M. DeAngelis et al.   DIABETES

Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance

(2008) M. Li et al.   DIABETES

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

(2008) J. Xu et al.   DIABETES

ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein inob/obmice

(2008) Zhouji Chen et al.   JOURNAL OF LIPID RESEARCH

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice

(2008) Stephen J. Peterson et al.   JOURNAL OF LIPID RESEARCH

NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes

(2008) R. E. Infante et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA